WCG Blog
Insights from the WIRB-Copernicus Group
-
Read PostThe Top Five Things You Need to Know about Hosting Virtual Investigator Training
-
Read PostUnsustainable and Burdensome: Today’s Safety Reporting Fails Sites, Sponsors and Patients
- Download Report
-
Read PostWCG Trifecta Introduces Virtual Certification for Atopic Dermatitis
-
Read PostOvercoming Three Study Training Challenges for Clinical Trials
-
Read PostPost-approval Pharmacovigilance: Support Along the Entire Lifecycle of Your Drug
-
Read Post
Five Tips for Improving Your Site's Study Start-Up Timelines
-
Read PostA Successful DMC Requires a Productive, Early Organizational Meeting
-
Read PostFive Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site
-
Read PostWhat Are Clinical Trials and How Do They Benefit Participants?
-
Read PostImprove Training, Increase Participation, Reduce Redundancy, & Cut Costs: Why Virtual Site Training is the New Norm
-
Read PostNew Study Uncovers the $966 Billion Economic Impact of Rare Diseases
-
Read PostBest Practices for Research Sites: Effectively Using Patient Recruitment Advertising Dollars
-
Read PostData and Biorepository Management During a Pandemic
-
Read PostInformed Consent: An IRB Perspective on Navigating the New Normal
-
Read PostNew Normal or Not, Safety Reporting Matters
-
Read PostThere is Value to Patients When Independent Sites Offer Clinical Trials
-
Read PostCOVID-19 Changed Everything: Now Contracts and Budgets Need to Catch Up
-
Read PostFour Tips For Navigating Patient Recruitment During COVID-19
-
Read PostWCG: Advocating for Patients in a time of COVID-19
-
Read PostCOVID-19 Insights from Former FDA Commissioner, Scott Gottlieb, MD
The coronavirus has spread beyond the point of containment, and there’s a looming shortage of personal protective equipment. Hear insights from former FDA Commissioner, Scott Gottlieb, MD.
-
Loading More...
